Suppr超能文献

[用于评估食管癌切除术后预后的DNA细胞计量术图像分析]

[Image analysis of DNA cytometry for assessing prognosis after resection of esophageal cancer].

作者信息

Böttger T, Störkel S, Stöckle M, Wahl W, Heintz A, Jugenheimer M, Effenberger-Kim O, Vinh T, Junginger T

机构信息

Klinik und Poliklinik für Allgemein und Abdominalchirurgie, Johannes-Gurenberg-Universität Mainz.

出版信息

Chirurg. 1991 Jun;62(6):467-72; discussion 472-3.

PMID:1655366
Abstract

Esophagus cancer is a heterogeneous disease with considerable differences in malignant behaviour. Some relevant factors for prognosis are known. In this study we analyzed DNA-ploidy as a potential prognostic parameter in esophagus carcinoma. Paraffin embedded histological material from 50 patients with an esophagus cancer, obtained by resection, were selected for analysis. Tumor areas within the paraffin material were identified by HE-stained reference sections. One 50 microns section was dewaxed, rehydrated and mechanically and enzymatically treated to a suspension of 10,000 cells/ml. 1 ml of the suspension, containing bare nuclei with small rests of cytoplasma was centrifuged on glass slides. The fixed nuclei were air-dried and stained by Feulgen-SITS technique, which allows quantitative measurement of DNA. The DNA analysis was carried out with a computer-controlled single cell cytophotometry (Leytas 2, Leitz, Wetzlar). In contrast to the flow cytometry with image cytometry only tumors cells were measured. Overlapping nuclei, dirt and other artefacts as well as inflammatory cells were efficiently eliminated. With the DNA image cytometry we could differentiate between diploid and hypotriploid, hypertriploid aneuploid tumors. Best prognosis had diploid and hypotriploid tumors, the worst hypertriploid carcinomas. In the multivariate analysis the DNA-content of the tumor cells in esophagus cancer was the only prognostic parameter. DNA-content of tumor cells may become considerably clinical relevant in esophagus cancer for the decision to perform a resection or palliative treatment. In patients with hypertriploid tumors an adjuvant oncological therapy may increase the prognosis.

摘要

食管癌是一种异质性疾病,其恶性行为存在显著差异。一些与预后相关的因素已为人所知。在本研究中,我们分析了DNA倍体作为食管癌潜在预后参数的情况。选取了50例经手术切除获得的食管癌患者的石蜡包埋组织学材料进行分析。通过苏木精-伊红(HE)染色参考切片确定石蜡材料中的肿瘤区域。将一张50微米厚的切片脱蜡、水化,经机械和酶处理制成10000个细胞/毫升的悬液。取1毫升该悬液(含有带有少量细胞质残余的裸核)在载玻片上离心。固定后的细胞核经空气干燥,采用福尔根-磺基水杨酸(Feulgen-SITS)技术染色,该技术可对DNA进行定量测量。DNA分析采用计算机控制的单细胞细胞光度测定法(Leytas 2,Leitz,韦茨拉尔)进行。与流式细胞术不同,图像细胞术仅测量肿瘤细胞。有效消除了重叠细胞核、污垢及其他伪像以及炎症细胞。通过DNA图像细胞术,我们能够区分二倍体、亚三倍体、超三倍体和非整倍体肿瘤。二倍体和亚三倍体肿瘤预后最佳,超三倍体癌预后最差。在多变量分析中,食管癌肿瘤细胞的DNA含量是唯一的预后参数。肿瘤细胞的DNA含量在食管癌中对于决定进行手术切除或姑息治疗可能具有相当大的临床意义。对于超三倍体肿瘤患者,辅助肿瘤治疗可能会改善预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验